## Core Concept
Human insulin and animal-derived insulin (from pork or beef) have differences in their amino acid sequences. Human insulin is produced through recombinant DNA technology, making it identical to naturally occurring human insulin. This process involves inserting the human insulin gene into bacteria or yeast, which then produce the insulin.

## Why the Correct Answer is Right
Human insulin, produced through recombinant DNA technology, has the same amino acid sequence as natural human insulin. In contrast, pork or beef insulin has slightly different amino acid sequences. This difference can lead to an immune response in some individuals, making human insulin less immunogenic compared to animal-derived insulin. The key advantage of human insulin is its reduced immunogenicity, which lowers the risk of developing insulin antibodies.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because human insulin does have a difference in its source and production method compared to pork/beef insulin.
- **Option B:** This option is incorrect as it does not accurately represent the primary advantage or difference of human insulin over animal-derived insulin.
- **Option C:** While the duration of action might be similar for some types of insulin, this option does not directly address the inherent differences between human and animal-derived insulin in terms of immunogenicity or production method.

## Clinical Pearl / High-Yield Fact
A crucial point to remember is that human insulin, due to its identical structure to natural human insulin, has a lower risk of inducing an immune response. This makes it a preferable option for patients who are likely to develop antibodies against insulin. A classic clinical correlation is that patients on long-term insulin therapy are less likely to develop insulin resistance or allergic reactions with human insulin compared to animal-derived insulin.

## Correct Answer: D. Less immunogenic.